Validating a multiplex immunofluorescence workflow to improve stratification of high-risk, early-stage melanoma samples
Lean about the benefits and limitations of quantitative multiplex immunofluorescence (qmIF) technology Find out how qmIF is used to stage patients with melanoma Discover how qmIF can lead to better treatment stratification of patients with melanoma Have the opportunity to ask questions during the live broadcast. Speaker: Yvonne Saenger, M.D., Columbia University Herbert Irving Comprehensive […]